Infusion helps repair COVID-19 damage in severe cases
New clues to prostate cancer: Why aggressive subtype can resist treatment
5 January 2021Child physical abuse encounters declined during COVID-19
5 January 2021Infusion helps repair COVID-19 damage in severe cases
University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine in January 2021.
